WeLeader Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	207.57	174.97	94.69	100.73	111.52
Short-Term Investments	87.95	34.37	7.83	8.4	4.18
Trading Asset Securities	3.12	2.83	2.43	2.33	3.01
Cash & Short-Term Investments	298.64	212.17	104.95	111.45	118.71
Cash Growth	47.08%	102.16%	-5.83%	-6.11%	-
Accounts Receivable	329.77	276.87	273.63	279.43	290.68
Other Receivables	-	0.02	0.05	0.1	1.03
Receivables	329.77	276.89	273.69	279.52	291.71
Inventory	126.66	99.06	69.67	62.73	55.89
Other Current Assets	5.36	3.2	2.11	1.02	2.11
Total Current Assets	760.43	591.32	450.42	454.73	468.42
Property, Plant & Equipment	1,499	1,341	1,194	1,086	351.66
Long-Term Investments	27.5	26.82	42.87	27.84	29.6
Other Intangible Assets	2.39	4.06	3.88	5.74	6.13
Long-Term Deferred Tax Assets	0.48	0.46	0.69	0.79	0.49
Other Long-Term Assets	33.78	34.63	36.02	25.24	26.8
Total Assets	2,323	1,998	1,728	1,600	883.09
Accounts Payable	215.65	183.54	143.19	155.28	160.65
Accrued Expenses	55.57	56.82	55.27	48.18	44.01
Short-Term Debt	50	80	57	121.03	53
Current Portion of Long-Term Debt	24.6	17.44	16.97	15.02	13.63
Current Portion of Leases	88.5	81.43	74.62	49.75	53.93
Current Income Taxes Payable	16.14	25.54	23.87	34.46	23.84
Current Unearned Revenue	5.17	1.52	0.34	0.7	1.95
Other Current Liabilities	22.37	22.71	30.43	14.13	12.81
Total Current Liabilities	478.01	469.01	401.69	438.54	363.81
Long-Term Debt	488.51	397.96	249.03	270.23	18.65
Long-Term Leases	210.46	219.94	228.38	245.22	142.99
Long-Term Deferred Tax Liabilities	0.02	-	-	-	0
Other Long-Term Liabilities	0.2	2.69	2.69	0.2	0.22
Total Liabilities	1,177	1,090	881.78	954.19	525.68
Common Stock	454.79	415.79	415.79	342.46	193.49
Additional Paid-In Capital	341.94	141.13	141.13	92.96	8.73
Retained Earnings	348.8	351.16	276.57	213.89	155.2
Comprehensive Income & Other	0.39	0.39	12.29	-3.01	-
Shareholders' Equity	1,146	908.47	845.78	646.3	357.41
Total Liabilities & Equity	2,323	1,998	1,728	1,600	883.09
Total Debt	862.06	796.77	626	701.25	282.19
Net Cash (Debt)	-563.42	-584.6	-521.05	-589.79	-163.49
Net Cash Per Share	-12.78	-14.01	-12.68	-19.38	-5.82
Filing Date Shares Outstanding	45.48	41.58	41.59	34.25	27.88
Total Common Shares Outstanding	45.48	41.58	41.59	34.25	27.88
Working Capital	282.42	122.31	48.73	16.19	104.61
Book Value Per Share	25.20	21.85	20.34	18.87	12.82
Tangible Book Value	1,144	904.41	841.9	640.56	351.28
Tangible Book Value Per Share	25.14	21.75	20.24	18.70	12.60
Land	652.61	652.61	652.61	657.23	4.62
Buildings	-	-	-	11.93	11.93
Machinery	20.01	19.46	28.53	25.97	24.65
Construction In Progress	488.13	318.14	144.95	7.43	0.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.